宝莱特（300246）8月25日主力资金净流出1000.36万元

Core Viewpoint - The financial performance of Baolait (300246) shows a mixed trend with a slight decrease in revenue but a significant increase in net profit, indicating potential areas for investment analysis [1] Financial Performance - As of the latest mid-year report, Baolait reported total revenue of 523 million yuan, a year-on-year decrease of 2.43% [1] - The net profit attributable to shareholders was 1.31 million yuan, reflecting a year-on-year increase of 152.22% [1] - The non-recurring net profit was 16.47 million yuan, which represents a year-on-year decrease of 6.80% [1] - The current ratio is 2.188, the quick ratio is 1.724, and the debt-to-asset ratio stands at 46.18% [1] Market Activity - As of August 25, 2025, Baolait's stock closed at 9.48 yuan, with a slight increase of 0.32% [1] - The trading volume was 109,200 hands, with a total transaction amount of 104 million yuan [1] - There was a net outflow of main funds amounting to 10.00 million yuan, accounting for 9.66% of the transaction amount [1] - Large orders saw a net outflow of 7.89 million yuan, while small orders experienced a net inflow of 2.02 million yuan [1] Company Background - Baolait Medical Technology Co., Ltd. was established in 1993 and is located in Zhuhai City, focusing on research and experimental development [2] - The company has invested in 21 enterprises and participated in 977 bidding projects [2] - Baolait holds 58 trademark registrations and 330 patents, along with 179 administrative licenses [2]